It is well established that the ferroptosis process could be affected by several key factors including GSH synthesis, GPX4 expression, activity of ferroptosis‐related enzymes and cellular iron abundance, and preliminary research exploiting these vulnerabilities has already generated positive therapeutic responses on xenograft tumor models in vivo.[126–15] However, James A. Olzmann et al. The gene discussed is GPX4; the disease is neoplasm.